+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Merck & Co., Inc. - logo

Merck & Co., Inc. is a global healthcare company with operations in more than 140 countries. It offers therapeutic and preventive agents to treat cardiovascular, type 2 diabetes, asthma, nasal allergy symptoms, allergic rhinitis, chronic hepatitis C virus and other diseases. The company has collaboration agreements with Adaptimmune Therapeutics plc and Agenus; and a research agreement with Proteros Biostructures. Founded in 1891, it is headquartered in Kenilworth, New Jersey.

Inhibitor Of Apoptosis (IAP) Antagonist- Pipeline Insight, 2025 - Product Thumbnail Image

Inhibitor Of Apoptosis (IAP) Antagonist- Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 60 Pages
  • Global
From
Eg5 Inhibitor - Pipeline Insight, 2025 - Product Thumbnail Image

Eg5 Inhibitor - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 60 Pages
  • Global
From
Beta-3 Receptors Agonist - Pipeline Insight, 2025 - Product Thumbnail Image

Beta-3 Receptors Agonist - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 60 Pages
  • Global
From
Indonesia Animal Health Market - Forecasts from 2021 to 2026 - Product Thumbnail Image

Indonesia Animal Health Market - Forecasts from 2021 to 2026

  • Report
  • June 2021
  • 93 Pages
  • Indonesia
From
Neuroblastoma Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update - Product Thumbnail Image

Neuroblastoma Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update

  • Report
  • October 2022
  • 308 Pages
  • Global
From
Gliosarcoma Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update - Product Thumbnail Image

Gliosarcoma Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update

  • Report
  • October 2022
  • 105 Pages
  • Global
From
The Corporate Reputation of Pharma in 2021- The Patient Perspective - Germany Edition - The Views of 151 German Patient Groups - Product Thumbnail Image

The Corporate Reputation of Pharma in 2021- The Patient Perspective - Germany Edition - The Views of 151 German Patient Groups

  • Report
  • August 2022
  • 59 Pages
  • Germany
Benign Prostatic Hyperplasia (BPH) Drugs - Global Strategic Business Report - Product Thumbnail Image

Benign Prostatic Hyperplasia (BPH) Drugs - Global Strategic Business Report

  • Report
  • November 2025
  • 182 Pages
  • Global
From
Non-Small Cell Lung Cancer Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update - Product Thumbnail Image

Non-Small Cell Lung Cancer Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update

  • Report
  • December 2022
  • 2271 Pages
  • Global
From
Molnupiravir Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2017-2027 Segmented By Application (Influenza, Ebola, COVID-19, Others), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies), By Region - Product Thumbnail Image

Molnupiravir Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2017-2027 Segmented By Application (Influenza, Ebola, COVID-19, Others), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies), By Region

  • Report
  • January 2023
  • 117 Pages
  • Global
From
Low-Density Lipoprotein Market - Global Forecast 2025-2030 - Product Thumbnail Image

Low-Density Lipoprotein Market - Global Forecast 2025-2030

  • Report
  • August 2025
  • 197 Pages
  • Global
From
The Corporate Reputation of Pharma in 2021 - The Patient Perspective - HIV/AIDS Edition -The Views of 168 HIV/AIDS Patient Groups - Product Thumbnail Image

The Corporate Reputation of Pharma in 2021 - The Patient Perspective - HIV/AIDS Edition -The Views of 168 HIV/AIDS Patient Groups

  • Report
  • June 2022
  • 91 Pages
  • Global
Lymphoma Global Market Insights 2022, Analysis and Forecast to 2027, by Manufacturers, Regions, Technology - Product Thumbnail Image

Lymphoma Global Market Insights 2022, Analysis and Forecast to 2027, by Manufacturers, Regions, Technology

  • Report
  • February 2022
  • 83 Pages
  • Global
From
Small-Cell Lung Cancer Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update - Product Thumbnail Image

Small-Cell Lung Cancer Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update

  • Report
  • November 2022
  • 574 Pages
  • Global
From
Cyclooxygenase 1 Inhibitors - Global Strategic Business Report - Product Thumbnail Image

Cyclooxygenase 1 Inhibitors - Global Strategic Business Report

  • Report
  • November 2025
  • 367 Pages
  • Global
From
Renal Cell Carcinoma Clinical Trial Analysis by Trial Phase, Trial Status, Trial Counts, End Points, Status, Sponsor Type and Top Countries, 2023 Update - Product Thumbnail Image

Renal Cell Carcinoma Clinical Trial Analysis by Trial Phase, Trial Status, Trial Counts, End Points, Status, Sponsor Type and Top Countries, 2023 Update

  • Report
  • May 2023
  • 1596 Pages
  • Global
From
Glioblastoma Treatment Drugs - Global Strategic Business Report - Product Thumbnail Image

Glioblastoma Treatment Drugs - Global Strategic Business Report

  • Report
  • November 2025
  • 287 Pages
  • Global
From
Malignant Glioma Therapeutics - Global Strategic Business Report - Product Thumbnail Image

Malignant Glioma Therapeutics - Global Strategic Business Report

  • Report
  • November 2025
  • 383 Pages
  • Global
From
Brain Tumor Therapeutics - Global Strategic Business Report - Product Thumbnail Image

Brain Tumor Therapeutics - Global Strategic Business Report

  • Report
  • November 2025
  • 182 Pages
  • Global
From
Brain Tumor Diagnosis and Treatment - Global Strategic Business Report - Product Thumbnail Image

Brain Tumor Diagnosis and Treatment - Global Strategic Business Report

  • Report
  • November 2025
  • 173 Pages
  • Global
From
Loading Indicator